Centaurus Financial’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Centaurus Financial’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-1,296	Closed	-$210K	–	920
2021 Q4	$210K	Sell	1,296 -536	-29%	-$86.7K	0.02%	666
2021 Q3	$304K	Sell	1,832 -2,054	-53%	-$351K	0.03%	546
2021 Q2	$671K	Sell	3,886 -56	-1%	-$9.25K	0.06%	353
2021 Q1	$633K	Buy	3,942 +90	+2%	+$15.4K	0.06%	319
2020 Q4	$647K	Sell	3,852 -222	-5%	-$36K	0.07%	308
2020 Q3	$641K	Sell	4,074 -825	-17%	-$135K	0.09%	239
2020 Q2	$822K	Buy	4,899 +3,214	+191%	+$504K	0.12%	197
2020 Q1	$221K	Buy	+1,685	New	+$240K	0.04%	321
2018 Q3	–	Sell	-56	Closed	-$8K	–	1023
2018 Q2	$8K	Buy	+56	New	+$7.69K	﹤0.01%	1626

Other funds holding FBT

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

BFG

Berger Financial Group Plymouth, Minnesota $1.79B AUM 15.72% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

Centaurus Financial's FBT Position: Q1 2022 in Review

Centaurus Financial sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q1 2022, closing a stake of 1,296 shares — an estimated $210K sold.

Centaurus Financial first reported a position in FBT in Q2 2018 and held it in 9 quarters. The position peaked at $822K in Q2 2020. 220 funds tracked by Wall St. Rank hold FBT as of Q1 2022.

Centaurus Financial reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q1 2022 after selling out during the quarter.
Centaurus Financial sold 1,296 First Trust NYSE Arca Biotechnology Index Fund shares in Q1 2022, an estimated $210K.
Centaurus Financial first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q2 2018 and held it in 9 quarters.
Centaurus Financial's First Trust NYSE Arca Biotechnology Index Fund position peaked at $822K in Q2 2020.
220 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q1 2022.

Based on Centaurus Financial's 13F filing for Q1 2022, filed 13 May 2022.